ロード中...
Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray (THC/CBD): Dimension and Possible Causes
Regulatory authorities admit clinical studies with an initial enrichment phase to select patients that respond to treatment before randomization (Enriched Design Studies; EDSs). The trial period aims to prevent long‐term drug exposure risks in patients with limited chances of improvement while optim...
保存先:
| 出版年: | CNS Neurosci Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495119/ https://ncbi.nlm.nih.gov/pubmed/25475413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12358 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|